Continuity Biosciences
PrivateLast Round
Series A
Aug 19, 2025
Total Funding Raised
$13.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Continuity Biosciences is a biotechnology company developing implantable and device-enabled platform technologies for cell reprogramming, immune modulation, and precision drug delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Continuity Biosciences Comparables
Compare Continuity Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Procyon Technologies LLC | 78% | |
| Encellin | 78% | |
| Persista Bio Inc. | 77% |
Continuity Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 19, 2025 | ||||
| Seed | Jun 4, 2025 | ||||
| Seed | Jun 18, 2024 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 387% MoM.
- Jun 30, 2026
Grew 21% QoQ from 19 to 23 employees.
Recent news
Latest coverage and updates
- hiresJul 30, 2026
Continuity Biosciences, LLC hired Vicky Papoutsis as Board of Directors. on Jul 30th '26.
Continuity Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Continuity Biosciences's valuation, stock price, and market status.
Is Continuity Biosciences a public or private company?
Continuity Biosciences is a private company.
What is the current stock price of Continuity Biosciences?
Continuity Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Continuity Biosciences worth (valuation)?
Valuation information for Continuity Biosciences is not publicly available.
Can I buy Continuity Biosciences stock?
Continuity Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Continuity Biosciences's last funding round?
Continuity Biosciences's most recent funding round was Series A on August 19, 2025.
Who are the main investors in Continuity Biosciences?
Investor information for Continuity Biosciences is not publicly disclosed.
Will Continuity Biosciences IPO soon?
No public IPO plans have been announced for Continuity Biosciences.
How can I track Continuity Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Continuity Biosciences's secondary market activity and sign up for updates.